JAGX - Jaguar Health, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
4.42M
Enterprise Value 3
25.46M
Trailing P/E
N/A
Forward P/E 1
-1.96
PEG Ratio (5 yr expected) 1
0.00
Price/Sales (ttm)
0.73
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
4.23
Enterprise Value/EBITDA 6
-1.05

Trading Information

Stock Price History

Beta (3Y Monthly) 1.36
52-Week Change 3-98.19%
S&P500 52-Week Change 36.64%
52 Week High 342.7000
52 Week Low 30.6410
50-Day Moving Average 31.1579
200-Day Moving Average 36.7929

Share Statistics

Avg Vol (3 month) 31.1M
Avg Vol (10 day) 3699.96k
Shares Outstanding 56.06M
Float 6.51M
% Held by Insiders 113.23%
% Held by Institutions 113.20%
Shares Short (Sep 30, 2019) 4549.61k
Short Ratio (Sep 30, 2019) 40.45
Short % of Float (Sep 30, 2019) 464.88%
Short % of Shares Outstanding (Sep 30, 2019) 49.01%
Shares Short (prior month Aug 30, 2019) 4146.43k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 270/1
Last Split Date 3Jun 7, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-428.38%

Management Effectiveness

Return on Assets (ttm)-39.23%
Return on Equity (ttm)-288.52%

Income Statement

Revenue (ttm)6.02M
Revenue Per Share (ttm)11.18
Quarterly Revenue Growth (yoy)93.00%
Gross Profit (ttm)-3.5M
EBITDA -24.27M
Net Income Avi to Common (ttm)-42.82M
Diluted EPS (ttm)-79.4530
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.61M
Total Cash Per Share (mrq)0.18
Total Debt (mrq)11.86M
Total Debt/Equity (mrq)161.29
Current Ratio (mrq)0.35
Book Value Per Share (mrq)-0.37

Cash Flow Statement

Operating Cash Flow (ttm)-16.48M
Levered Free Cash Flow (ttm)-3.42M